Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 60.9 TWD 0.5% Market Closed
Market Cap: 10.9B TWD

Wall Street
Price Targets

Price Targets Summary
Standard Chem & Pharm Co Ltd

There are no price targets for Standard Chem & Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Standard Chem & Pharm Co Ltd Competitors:
Price Targets
INVA
Innoviva Inc
68% Upside
4151
Kyowa Kirin Co Ltd
7% Upside
4521
Kaken Pharmaceutical Co Ltd
12% Upside
053030
Binex Co Ltd
93% Upside
MEGA
Mega Lifesciences PCL
0% Upside
688526
Wuhan Keqian Biology Co Ltd
37% Upside
AMRX
Amneal Intermediate Inc
12% Upside
PHO
Photocure ASA
3% Upside

Revenue
Forecast

Revenue Estimate
Standard Chem & Pharm Co Ltd

For the last 13 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's revenue is 6%. The projected CAGR for the next 1 year is 7%.

6%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Standard Chem & Pharm Co Ltd

For the last 13 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's operating income is 16%. The projected CAGR for the next 1 year is 11%.

16%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Standard Chem & Pharm Co Ltd

For the last 13 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's net income is 10%. The projected CAGR for the next 1 year is 8%.

10%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Standard Chem & Pharm Co Ltd's stock price target?
Not Available

Standard Chem & Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Standard Chem & Pharm Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's revenue is 6%. The projected CAGR for the next 1 year is 7%.

What is Standard Chem & Pharm Co Ltd's Operating Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's operating income is 16%. The projected CAGR for the next 1 year is 11%.

What is Standard Chem & Pharm Co Ltd's Net Income forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's net income is 10%. The projected CAGR for the next 1 year is 8%.

Back to Top